Ross Keller

Ross Keller, PhD, has a diverse background in cancer research and teaching. Ross most recently worked as a Research Director at Private Health Management, where they managed cancer cases and connected patients with the best treatment options based on clinical and preclinical data. Prior to that, they were a Research Fellow at Memorial Sloan Kettering Cancer Center, where they studied the development of childhood brain cancer and evaluated the efficacy of DNA damage repair inhibitors. Ross also worked as a Graduate Researcher at Penn State University, where they discovered a novel mechanism of tumor driver mutation selection and studied the effects of ionizing radiation on mutation spectra in breast cancer. In addition, they served as a Teaching Assistant at St. Olaf College, where they taught and assessed undergraduate students in biology and chemistry. Ross began their research career as an Undergraduate Researcher at North Dakota State University, investigating the molecular mechanisms of parasitic infection.

Ross Keller, PhD, obtained their Bachelor of Arts (B.A.) degree in Biology and Chemistry from St. Olaf College, where they studied from 2007 to 2011. Following this, they pursued their doctoral degree in Biomedical Sciences with a focus on Biochemistry and Molecular Genetics at Penn State College of Medicine. Ross completed their PhD program from 2011 to 2018, earning the title of Doctor of Philosophy.